The Journal of Urology · 2011 · 60 citations · 20 references
MedicineEndocrinologyOncologyMolecular OncologyProstate DiseaseTranslational OncologyAndrogen Deprivation TherapyOxidative StressOxidative Stress In CarcinogenesisOxidative Stress MechanismsProstate CancerSteroid Hormone SignalingAndrogen Deprivation Therapy ResistanceAndrogen Receptor ExpressionAndrogen Receptor RegulationAndrogen ReceptorsNeoadjuvant Androgen Deprivation TherapyOxidative Stress In CancerOxidative Stress InjuryProstate Cancer Histopathology
PURPOSE: Prostate cancer progression from androgen dependence to castration resistance results at least in part from oxidative stress induced by androgen deprivation therapy. We elucidated the state and the role of oxidative stress induced by androgen deprivation therapy and the possibility of antioxidant therapy in human prostate cancer. MATERIALS AND METHODS: We investigated 4-HNE (4-hydroxy-2-nonenal histidine adduct) staining, and Twist1, YB-1 and androgen receptor expression by immunohistochemistry in prostate cancer samples treated with or without neoadjuvant androgen deprivation therapy. Intracellular reactive oxygen species and protein expression were examined by CM-H(2)DCFDA and Western blot analysis, respectively. A cell proliferation assay and a mouse xenograft model were used to assess tumor growth. RESULTS: Androgen deprivation therapy increased oxidative stress, as shown by 4-HNE staining in human prostate cancer tissue. Twist1 and YB-1 expression was up-regulated by androgen deprivation, resulting in androgen receptor over expression. In LNCaP and 22Rv1 cells androgen deprivation increased intracellular reactive oxygen species and evoked Twist1, YB-1 and androgen receptor over expression, resulting in cell growth in a castration resistant manner. Growth was alleviated by N-acetyl-cysteine, an electrophile that supports glutathione production. N-acetyl-cysteine also decreased LNCaP and 22Rv1 tumor growth in castrated and noncastrated mice. CONCLUSIONS: Androgen deprivation therapy induced oxidative stress in in vitro and human prostate cancer. Antioxidant therapy using N-acetyl-cysteine appears to be a promising therapeutic modality for prostate cancer.
20
Molecular determinants of resistance to antiandrogen therapy
Charlie D. Chen, Derek S. Welsbie, Chris Tran et al. · Nature Medicine · 2003 · 2.3K citations
Medicine, Endocrinology, Urology +17
Prognostic and predictive factors in breast cancer by immunohistochemical analysis.
D. Craig Allred, Jennet Harvey, Melora D. Berardo et al. · PubMed · 1998 · 2.2K citations
Medicine, Cancer Biology, Oncology +16
Mitogenic Signaling Mediated by Oxidants in Ras-Transformed Fibroblasts
Kaikobad Irani, Yong Xia, Jay L. Zweíer et al. · Science · 1997 · 1.6K citations
Scott M. Dehm, Lucy J. Schmidt, Hannelore V. Heemers et al. · Cancer Research · 2008 · 836 citations · Full text